Walleye Capital LLC Invitae Corp Transaction History

Walleye Capital LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.9 - $8.63 $1.06 Million - $4.81 Million	-557,730 Reduced 78.68%	151,156 $372,000
Q2 2022 Aug 08, 2022	BUY	$2.13 - $9.01 $1.32 Million - $5.58 Million	619,822 Added 695.93%	708,886 $1.73 Million
Q1 2022 May 16, 2022	BUY	$6.28 - $15.59 $316,373 - $785,393	50,378 Added 130.22%	89,064 $710,000
Q4 2021 Mar 03, 2022	BUY	$14.7 - $28.67 $568,684 - $1.11 Million	38,686 New	38,686 $590,000
Q4 2019 Feb 14, 2020	SELL	$15.02 - $20.57 $124,305 - $170,237	-8,276 Closed	0 $0

Q3 2019 Nov 14, 2019	BUY	$18.85 - $27.5 $140,564 - $205,067	7,457 Added 910.5%	8,276 $159,000
Q2 2019 Aug 14, 2019	BUY	$17.37 - $26.27 $14,226 - $21,515	819 New	819 $19,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.